The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug-Reference-Cited by-同舟云学术

The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug

Published:2016-06-27 Issue:30 Volume:7 Page:48467-48480
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Song Ping¹,Yao Xin²¹,Zhong Ting²¹,Zhang Shuang²¹,Guo Yang²¹,Ren Wei²¹,Huang Dan²¹,Duan Xiao-Chuan²¹,Yin Yi-Fan²,Zhang Shu-Shi²,Zhang Xuan²¹

Affiliation:

1. Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China

2. Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy;International Journal of Nanomedicine;2023-03

2. The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death;Drug Delivery;2021-01-01

3. Design, synthesis and biological evaluation of a novel platinum(II) complex possessing bioreductive groups for cancer therapy;Chinese Chemical Letters;2019-01

4. Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo;International Journal of Nanomedicine;2018-12

5. Photoresponsive Drug/Gene Delivery Systems;Biomacromolecules;2018-04-27